OXFENDAZOLE DEVELOPMENT GROUP

The Oxfendazole Development Group (ODG) is a US based nonprofit organization founded by clinical and nonclinical scientists from three continents with the aim of developing an improved medicine for the treatment of some Neglected Tropical Diseases. Further, ODG aims to make any treatment successfully developed available to people who need it, without regards to profit... Oxfendazole Development Group Receives Grant from Open Philanthropy The Oxfendazole Development Group (ODG) announces that it has received a grant of $1.6 million from Open Philanthropy (https://www.openphilanthropy.org/) to carry out nonclinical toxicology studies on oxfendazole, a veterinary deworming medicine that it is developing for human use. Having successfully completed Phase 1 Single Ascending Dose (SAD).